Amylyx Pharmaceuticals(AMLX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AMLX Amylyx Pharmaceuticals

已收盘 07-14 16:00:00 EDT

8.41

+0.73

+9.51%

盘后8.45

+0.04+0.48%

19:58 EDT

最高8.47	最低7.76	成交量234.09万
今开8.02	昨收7.68	日振幅9.18%
总市值7.50亿	流通市值4.29亿	总股本8,914万
成交额1,930万	换手率4.59%	流通股本5,098万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"AMLX","market":"US","secType":"STK","nameCN":"Amylyx Pharmaceuticals","latestPrice":8.41,"timestamp":1752523200000,"preClose":7.68,"halted":0,"volume":2340913,"hourTrading":{"tag":"盘后","latestPrice":8.45,"preClose":8.41,"latestTime":"19:58 EDT","volume":22389,"amount":188327.5628,"timestamp":1752537524872},"delay":0,"floatShares":50976320,"shares":89141087,"eps":-3.016186,"marketStatus":"已收盘","change":0.73,"latestTime":"07-14 16:00:00 EDT","open":8.02,"high":8.465,"low":7.76,"amount":19295900.063135,"amplitude":0.091797,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.016186,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752566400000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1641531600000,"exchange":"NASDAQ","adjPreClose":7.68,"dividendRate":0.000119,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":7.97,"preClose":7.68,"latestTime":"09:27 EDT","volume":43938,"amount":361276.51420800004,"timestamp":1752499670102},"postHourTrading":{"tag":"盘后","latestPrice":8.45,"preClose":8.41,"latestTime":"19:58 EDT","volume":22389,"amount":188327.5628,"timestamp":1752537524872},"volumeRatio":1.191317,"impliedVol":0.3266,"impliedVolPercentile":0.096},"requestUrl":"/m/hq/s/AMLX","defaultTab":"news","newsList":[{"id":"2551184049","title":"Amylyx Pharmaceuticals, Inc.盘中异动 股价大涨5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551184049","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551184049?lang=zh_cn&edition=full","pubTime":"2025-07-14 21:30","pubTimestamp":1752499858,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日21时30分，Amylyx Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.73%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Dare Bioscience, Inc.、Sonnet Biotherapeutics Holdings, Inc.、Biomx Inc.涨幅较大，Windtree Therapeutics, Inc.、Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.较为活跃，换手率分别为1599.55%、454.36%、301.17%，振幅较大的相关个股有Biomx Inc.、Kairos Pharma, Ltd.、Sonnet Biotherapeutics Holdings, Inc.，振幅分别为9.04%、6.89%、5.80%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc 是一家处于临床阶段的制药公司，致力于开发治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714213058a6a8efa7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714213058a6a8efa7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2550718673","title":"Amylyx Pharmaceuticals, Inc.盘中异动 股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550718673","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550718673?lang=zh_cn&edition=full","pubTime":"2025-07-11 03:12","pubTimestamp":1752174771,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日03时12分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.11%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.88%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc 是一家处于临床阶段的制药公司，致力于开发治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711031252a4431841&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711031252a4431841&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2550657378","title":"Amylyx Pharmaceuticals, Inc.盘中异动 大幅上涨5.01%报7.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550657378","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550657378?lang=zh_cn&edition=full","pubTime":"2025-07-10 01:39","pubTimestamp":1752082783,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日01时39分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.01%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.97%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc 是一家处于临床阶段的制药公司，致力于开发治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710013943a69fdb07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710013943a69fdb07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2549559170","title":"Amylyx Pharmaceuticals, Inc.盘中异动 股价大涨5.08%报6.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549559170","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549559170?lang=zh_cn&edition=full","pubTime":"2025-07-08 00:18","pubTimestamp":1751905127,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日00时18分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.08%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。其相关个股中，Mustang Bio, Inc.、Pelthos Therapeutics Inc.、Artelo Biosciences, Inc.涨幅较大，Mustang Bio, Inc.、Artelo Biosciences, Inc.、Sonnet Biotherapeutics Holdings, Inc.较为活跃，换手率分别为5602.64%、1193.45%、869.55%，振幅较大的相关个股有Mustang Bio, Inc.、Pelthos Therapeutics Inc.、Artelo Biosciences, Inc.，振幅分别为298.32%、233.18%、84.08%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc 是一家处于临床阶段的制药公司，致力于开发治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708001848979d39b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708001848979d39b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2548193248","title":"Amylyx Pharmaceuticals, Inc.盘中异动 临近午盘股价大涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548193248","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548193248?lang=zh_cn&edition=full","pubTime":"2025-07-02 23:56","pubTimestamp":1751471763,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日23时56分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.15%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.02%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc 是一家处于临床阶段的制药公司，致力于开发治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070223560395341dfc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070223560395341dfc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2546441027","title":"Amylyx Pharmaceuticals, Inc.盘中异动 早盘急速下跌5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546441027","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546441027?lang=zh_cn&edition=full","pubTime":"2025-06-27 21:43","pubTimestamp":1751031785,"startTime":"0","endTime":"0","summary":"北京时间2025年06月27日21时43分，Amylyx Pharmaceuticals, Inc.股票出现异动，股价快速下跌5.34%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc 是一家处于临床阶段的制药公司，致力于开发治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627214306a7210908&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627214306a7210908&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2546617245","title":"Amylyx Pharmaceuticals, Inc.盘中异动 急速跳水5.62%报6.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546617245","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546617245?lang=zh_cn&edition=full","pubTime":"2025-06-25 21:36","pubTimestamp":1750858566,"startTime":"0","endTime":"0","summary":"北京时间2025年06月25日21时36分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.62%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.53%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc 是一家处于临床阶段的制药公司，致力于开发治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625213606a4bd719e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625213606a4bd719e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2545121238","title":"Amylyx Pharmaceuticals, Inc.盘中异动 大幅拉升7.57%报5.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545121238","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545121238?lang=zh_cn&edition=full","pubTime":"2025-06-24 21:32","pubTimestamp":1750771945,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日21时32分，Amylyx Pharmaceuticals, Inc.股票出现异动，股价急速拉升7.57%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc 是一家处于临床阶段的制药公司，致力于开发治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新型疗法。该信息摘要如下：Amylyx Pharmaceuticals获Guggenheim首次覆盖，给予买入评级, 目标价17.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624213225a4bb9617&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624213225a4bb9617&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2545828297","title":"Amylyx Pharmaceuticals获Guggenheim首次覆盖，给予买入评级, 目标价17.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2545828297","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545828297?lang=zh_cn&edition=full","pubTime":"2025-06-24 20:11","pubTimestamp":1750767114,"startTime":"0","endTime":"0","summary":"Amylyx Pharmaceuticals(AMLX.US)获Guggenheim首次覆盖，给予买入评级, 目标价17.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062420145795298e1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062420145795298e1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMLX"],"gpt_icon":0},{"id":"2544964977","title":"Amylyx Pharmaceuticals(AMLX.US)获花旗首次覆盖，给予买入评级, 目标价12.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2544964977","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544964977?lang=zh_cn&edition=full","pubTime":"2025-06-17 19:44","pubTimestamp":1750160645,"startTime":"0","endTime":"0","summary":"Amylyx Pharmaceuticals(AMLX.US)获花旗首次覆盖，给予买入评级, 目标价12.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/17194451125661.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AMLX"],"gpt_icon":0},{"id":"2542345025","title":"Amylyx Pharmaceuticals, Inc.盘中异动 股价大涨5.33%报5.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542345025","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542345025?lang=zh_cn&edition=full","pubTime":"2025-06-10 23:34","pubTimestamp":1749569651,"startTime":"0","endTime":"0","summary":"北京时间2025年06月10日23时34分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.33%。截至发稿，该股报5.73美元/股，成交量39.0589万股，换手率0.44%，振幅5.42%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc 是一家处于临床阶段的制药公司，致力于开发治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610233412a4a2262e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610233412a4a2262e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2541860196","title":"Amylyx Pharmaceuticals, Inc.盘中异动 下午盘股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2541860196","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541860196?lang=zh_cn&edition=full","pubTime":"2025-06-07 03:11","pubTimestamp":1749237102,"startTime":"0","endTime":"0","summary":"北京时间2025年06月07日03时11分，Amylyx Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.05%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。其相关个股中，Phathom Pharmaceuticals, Inc.、Eyenovia, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Nucana Plc、Eyenovia, Inc.、Glycomimetics, Inc.较为活跃，换手率分别为4493.61%、1183.72%、89.11%，振幅较大的相关个股有Phathom Pharmaceuticals, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Eyenovia, Inc.，振幅分别为162.26%、99.50%、74.84%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc 是一家处于临床阶段的制药公司，致力于开发治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506070311429511adec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506070311429511adec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2540977427","title":"Amylyx Pharmaceuticals, Inc.盘中异动 股价大跌5.05%报4.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540977427","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540977427?lang=zh_cn&edition=full","pubTime":"2025-06-03 01:48","pubTimestamp":1748886538,"startTime":"0","endTime":"0","summary":"北京时间2025年06月03日01时48分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价快速跳水5.05%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.77%。其相关个股中，Lyra Therapeutics, Inc.、Plus Therapeutics, Inc.、Nutriband Inc C/Wts 涨幅较大，Lyra Therapeutics, Inc.、Oragenics Inc.、Plus Therapeutics, Inc.较为活跃，换手率分别为1809.17%、1226.08%、709.70%，振幅较大的相关个股有Lyra Therapeutics, Inc.、Oragenics Inc.、Plus Therapeutics, Inc.，振幅分别为314.40%、130.92%、122.34%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc 是一家处于临床阶段的制药公司，致力于开发治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603014858950bc225&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603014858950bc225&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2539272423","title":"Amylyx Pharmaceuticals, Inc.盘中异动 下午盘急速拉升5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2539272423","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539272423?lang=zh_cn&edition=full","pubTime":"2025-05-31 02:35","pubTimestamp":1748630106,"startTime":"0","endTime":"0","summary":"北京时间2025年05月31日02时35分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.31%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为3.77%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc 是一家处于临床阶段的制药公司，致力于开发治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250531023507a6f3af22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250531023507a6f3af22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2538460460","title":"Amylyx Pharmaceuticals, Inc.盘中异动 快速跳水5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2538460460","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538460460?lang=zh_cn&edition=full","pubTime":"2025-05-27 22:54","pubTimestamp":1748357647,"startTime":"0","endTime":"0","summary":"北京时间2025年05月27日22时54分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.08%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.25%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc 是一家处于临床阶段的制药公司，致力于开发治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527225407aa2c9a49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527225407aa2c9a49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2537159395","title":"Amylyx Pharmaceuticals, Inc.盘中异动 快速下挫5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537159395","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537159395?lang=zh_cn&edition=full","pubTime":"2025-05-24 02:01","pubTimestamp":1748023304,"startTime":"0","endTime":"0","summary":"北京时间2025年05月24日02时01分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.04%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.54%。其相关个股中，Imunon, Inc.、Protagenic Therapeutics Inc C/Wts 26/04/2026 、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Polyrizon Ltd.、Imunon, Inc.、Nucana Plc较为活跃，换手率分别为4429.63%、2298.67%、1106.04%，振幅较大的相关个股有Abpro Holdings Inc C/Wts 12/11/2029 、Protagenic Therapeutics Inc C/Wts 26/04/2026 、Imunon, Inc.，振幅分别为208.33%、170.40%、101.08%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc 是一家处于临床阶段的制药公司，致力于开发治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052402014497637f17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052402014497637f17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2537953033","title":"Amylyx Pharmaceuticals, Inc.盘中异动 下午盘大幅下跌5.16%报5.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537953033","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537953033?lang=zh_cn&edition=full","pubTime":"2025-05-22 02:04","pubTimestamp":1747850643,"startTime":"0","endTime":"0","summary":"北京时间2025年05月22日02时04分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价大幅下挫5.16%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.31%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc 是一家处于临床阶段的制药公司，致力于开发治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052202040397610b4d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052202040397610b4d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2536360516","title":"Amylyx Pharmaceuticals, Inc.盘中异动 股价大涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536360516","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536360516?lang=zh_cn&edition=full","pubTime":"2025-05-20 00:06","pubTimestamp":1747670816,"startTime":"0","endTime":"0","summary":"北京时间2025年05月20日00时06分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.17%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc 是一家处于临床阶段的制药公司，致力于开发治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052000065694fbaf0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052000065694fbaf0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2536582686","title":"Amylyx Pharmaceuticals, Inc.2025财年第一财季实现净利润-35.91百万美元，同比增加69.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536582686","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536582686?lang=zh_cn&edition=full","pubTime":"2025-05-18 00:00","pubTimestamp":1747497625,"startTime":"0","endTime":"0","summary":"5月18日，Amylyx Pharmaceuticals, Inc.公布财报，公告显示公司2025财年第一财季净利润为-35.91百万美元，同比增加69.82%；其中营业收入为0.00美元，每股基本收益为-0.42美元。机构评级：截至2025年5月18日，当前有5家机构对Amylyx Pharmaceuticals, Inc.目标价做出预测，其中目标均价为10.80美元，其中最低目标价为8.00美元，最高目标价为16.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000132a4821d9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000132a4821d9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMLX"],"gpt_icon":0},{"id":"2536344131","title":"Amylyx Pharmaceuticals, Inc.盘中异动 下午盘股价大涨5.20%报4.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536344131","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536344131?lang=zh_cn&edition=full","pubTime":"2025-05-17 02:56","pubTimestamp":1747421770,"startTime":"0","endTime":"0","summary":"北京时间2025年05月17日02时56分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.20%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.28%。其相关个股中，Affimed N.V.、Inozyme Pharma, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Affimed N.V.、Polyrizon Ltd.、Nucana Plc较为活跃，换手率分别为5275.81%、3793.89%、1703.79%，振幅较大的相关个股有Affimed N.V.、Onconetix, Inc.、Vor Biopharma Inc.，振幅分别为466.98%、66.89%、66.82%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc 是一家处于临床阶段的制药公司，致力于开发治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517025611aa2c91c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517025611aa2c91c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMLX","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.amylyx.com","stockEarnings":[{"period":"1week","weight":0.219},{"period":"1month","weight":0.417},{"period":"3month","weight":1.1041},{"period":"6month","weight":1.1943},{"period":"1year","weight":2.3684},{"period":"ytd","weight":1.0317}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.037},{"period":"3month","weight":0.168},{"period":"6month","weight":0.0743},{"period":"1year","weight":0.1207},{"period":"ytd","weight":0.0641}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Amylyx Pharmaceuticals, Inc.于2014年1月10日根据特拉华州法律成立。该公司是一家临床阶段的制药公司，其使命是为医疗需求未得到满足的社区开发和推进新疗法。该公司在神经退行性疾病和内分泌疾病方面正在进行临床前和临床开发项目。该公司正在推进一项管道，在该管道中，该公司已将研究性疗法与认为这些疗法可以产生最大影响的疾病相匹配，基于明确定义的机制原理、明确的临床结果和生物标志物，以及严格的临床前数据，与模式无关。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.037729},{"month":2,"riseRate":0.5,"avgChangeRate":0.096144},{"month":3,"riseRate":0.25,"avgChangeRate":-0.384218},{"month":4,"riseRate":0.25,"avgChangeRate":-0.062706},{"month":5,"riseRate":0.25,"avgChangeRate":-0.046188},{"month":6,"riseRate":0.75,"avgChangeRate":0.347356},{"month":7,"riseRate":1,"avgChangeRate":0.192712},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.022589},{"month":9,"riseRate":0.666667,"avgChangeRate":0.141337},{"month":10,"riseRate":0.666667,"avgChangeRate":0.274859},{"month":11,"riseRate":0.666667,"avgChangeRate":-0.010067},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.10505}],"exchange":"NASDAQ","name":"Amylyx Pharmaceuticals","nameEN":"Amylyx Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Amylyx Pharmaceuticals(AMLX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Amylyx Pharmaceuticals(AMLX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Amylyx Pharmaceuticals,AMLX,Amylyx Pharmaceuticals股票,Amylyx Pharmaceuticals股票老虎,Amylyx Pharmaceuticals股票老虎国际,Amylyx Pharmaceuticals行情,Amylyx Pharmaceuticals股票行情,Amylyx Pharmaceuticals股价,Amylyx Pharmaceuticals股市,Amylyx Pharmaceuticals股票价格,Amylyx Pharmaceuticals股票交易,Amylyx Pharmaceuticals股票购买,Amylyx Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Amylyx Pharmaceuticals(AMLX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Amylyx Pharmaceuticals(AMLX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}